Carlo Andrea Pivato completed medical training at Vita-Salute San Raffaele University (Milan), followed by cardiology residency at Humanitas University (Milan). He conducted a research fellowship at the Icahn School of Medicine at Mount Sinai (New York) and obtained a PhD in Data Science and Medicine from Humanitas University, including a research period at the Health Data Science Center, Human Technopole (Milan). He specialized in echocardiography at Humanitas Research Hospital, where he currently practices as a cardiologist, and also serves at Humanitas Mater Domini.
Carlo Andrea Pivato’s research focuses on clinical cardiology, particularly valvular and ischemic heart disease, optimization of antithrombotic therapy, and precise stratification of ischemic and bleeding risk in patients undergoing invasive cardiovascular procedures. His work integrates advanced statistical modeling and artificial intelligence to enhance causal inference and develop predictive tools. He also has extensive expertise in meta-analysis, clinical epidemiology, and the design and methodology of clinical trials.
- Pivato CA, Di Angelantonio E, Tartaglia F, Condorelli G, Fontana N, Ieva F, Godino C, Nakase M, Hug K, Rheude T, Munoz-Garcia AJ, Jimenez Diaz VA, Ielasi A, Barbanti M, Costa G, Anzuini A, Quadri G, Lopez-Otero D, Garot P, Varbella F, Brouwer J, Gramss L, Cao D, Figliozzi S, Regazzoli D, Testa L, Sanz Sanchez J, Tomii D, Chieffo A, Joner M, Sardella G, Cerrato E, Nombela-Franco L, Pilgrim T, Stefanini G. Impact of Valve Frame Height on PCI Outcomes After TAVR. JACC Cardiovasc Interv. 2025 Oct 25:S1936-8798(25)02482-3. doi: 10.1016/j.jcin.2025.09.030. Epub ahead of print. PMID: 41137839.
- Pivato CA, Inversetti A, Condorelli G, Chieffo A, Levi-Setti PE, Latini AC, Busnelli A, Messa M, Cristodoro M, Bragato RM, Francone M, Zuccolo L, Ieva F, Di Angelantonio E, Stefanini G, Di Simone N. Cardiovascular safety of assisted reproductive technology: a meta-analysis. Eur Heart J. 2025 Feb 21;46(8):687-698. doi: 10.1093/eurheartj/ehae886. PMID: 39710934.
- Pivato CA, Stefanini G, Giacoppo D, Sideris G, Testa L, Paunovic D, Briguori C, Indolfi C, Reimers B, Sinnaeve P, Varenne O. One-month DAPT after biodegradable-polymer everolimus-eluting stent implantation in patients at high-bleeding risk: an individual patient data pooled analysis of the SENIOR and POEM trials. Eur Heart J Open. 2024 Aug 6;4(4):oeae068. doi: 10.1093/ehjopen/oeae068. PMID: 39175846; PMCID: PMC11339713
- Pivato CA, Reimers B, Testa L, Pacchioni A, Briguori C, Musto C, Esposito G, Piccolo R, Lucisano L, De Luca L, Conrotto F, De Marco A, Franzone A, Presbitero P, Ferrante G, Condorelli G, Paradies V, Sardella G, Indolfi C, Condorelli G, Stefanini GG. One-Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus-Eluting Stents in High Bleeding Risk Patients. J Am Heart Assoc. 2022 Mar 15;11(6):e023454. doi: 10.1161/JAHA.121.023454. Epub 2022 Feb 3. Erratum in: J Am Heart Assoc. 2022 Aug 16;11(16):e020787. doi: 10.1161/JAHA.121.020787. PMID: 35114814; PMCID: PMC9075308
- Mehran R, Owen R, Chiarito M, Baber U, Sartori S, Cao D, Nicolas J, Pivato CA, Nardin M, Krishnan P, Kini A, Sharma S, Pocock S, Dangas G. A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry. Lancet. 2021 Nov 27;398(10315):1974-1983. doi: 10.1016/S0140-6736(21)02326-6. Epub 2021 Nov 15. PMID: 34793743.